|
|
| | MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan Basic information |
| | MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan Chemical Properties |
| density | 1.48±0.1 g/cm3(Predicted) | | pka | 11.18±0.40(Predicted) | | form | Solid | | color | Off-white to light yellow |
| | MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan Usage And Synthesis |
| Uses | MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan is a agent-linker conjugates for ADC, consisting Exatecan (HY-13631). Exatecan is a DNA Topoisomerase I inhibitor (IC50=2.2 μM)[1]. | | IC 50 | Camptothecins | | References | [1] Ying Hua, et al. Anti-B7H3 antibody-exatecan analog conjugate and medicinal use thereof: World Intellectual Property Organization, WO2020063673. 2020-04-02. |
| | MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan Preparation Products And Raw materials |
|
|
Tag:MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan(2414254-52-5)
Related Product Information
|
|
ZBH-1205
Mal-PEG8-Phe-Lys-PAB-Exatecan TFA
Exatecan mesylate dihydrate
Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]-
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 11-(aminomethyl)-4-ethyl-8-fluoro-4-hydroxy-9-methyl-, (4S)-
Glycine, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-9-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl ester, hydrochloride (1:1)
|